Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

2.

[Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].

Wu Y, Xue Y, Chen S, Yao L, Jiang H, Zhang J, Shen J, Pan J, Wang Y, Bai S.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Feb;27(1):86-91. doi: 10.3760/cma.j.issn.1003-9406.2010.01.019. Chinese.

PMID:
20140876
3.

Efficacy of DSP30-IL2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma.

Holmes PJ, Peiper SC, Uppal GK, Gong JZ, Wang ZX, Bajaj R.

Int J Lab Hematol. 2016 Oct;38(5):483-9. doi: 10.1111/ijlh.12513. Epub 2016 Aug 27.

PMID:
27565124
4.

Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.

Put N, Konings P, Rack K, Jamar M, Van Roy N, Libouton JM, Vannuffel P, Sartenaer D, Ameye G, Speleman F, Herens C, Poirel HA, Moreau Y, Hagemeijer A, Vandenberghe P, Michaux L; Belgian Cytogenetic Group for Hemato-Oncology (BCGHO).

Genes Chromosomes Cancer. 2009 Oct;48(10):843-53. doi: 10.1002/gcc.20691.

PMID:
19582829
5.

[Chromosome banding analysis of peripheral blood lymphocytes stimulated with IL2 and CpG oligonucleotide DSP30 in patients with chronic lymphocytic leukemia].

Stěpanovská K, Vaňková G, Némethová V, Tomášiková L, Smuhařová P, Divíšková E, Vallová V, Kuglík P, Plevová K, Oltová A, Doubek M, Pospíšilová S, Mayer J.

Klin Onkol. 2013;26(4):263-70. Czech.

PMID:
23961857
6.
7.

Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.

Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T.

Leukemia. 2007 Dec;21(12):2442-51. Epub 2007 Sep 6.

PMID:
17805327
8.

[Cytogenetics of chronic lymphocytic leukemia stimulated by CpG-oligodeoxynucleotides and IL-2].

Wang DM, Xu W, Dong HJ, Fang C, Zhu DX, Cao X, Zhu HY, Zhuang Y, Qiu HR, Yang H, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1114-8. Chinese.

PMID:
21129242
9.

[Chromosomal aberrations in chronic lymphocytic leukemia by interphase fluorescence in situ hybridization and their association with clinical features].

Li WJ, Guo L, Hou M, Sun JZ, Shao LL, Wang SK, Ma DX.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Apr;18(2):494-8. Chinese.

PMID:
20416197
10.

Cytogenetic investigations of chronic lymphocytic leukemia.

Wren C, Moriarty H, Marsden K, Tegg E.

Cancer Genet Cytogenet. 2010 Apr 15;198(2):155-61. doi: 10.1016/j.cancergencyto.2009.12.014.

PMID:
20362231
11.

Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulation.

Shi M, Cipollini MJ, Crowley-Bish PA, Higgins AW, Yu H, Miron PM.

Am J Clin Pathol. 2013 May;139(5):662-9. doi: 10.1309/AJCP7G4VMYZJQVFI.

PMID:
23596118
12.

Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent: comparison with FISH.

Kotkowska A, Wawrzyniak E, Blonski JZ, Robak T, Korycka-Wolowiec A.

Leuk Res. 2011 Aug;35(8):1032-8. doi: 10.1016/j.leukres.2011.01.020. Epub 2011 Feb 17.

PMID:
21333354
13.

FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia.

Dubuc AM, Davids MS, Pulluqi M, Pulluqi O, Hoang K, Hernandez-Sánchez JM, Schlich C, Hernández-Rivas JM, Brown JR, Dal Cin P.

Am J Hematol. 2016 Oct;91(10):978-83. doi: 10.1002/ajh.24452. Epub 2016 Jul 22.

14.

Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study.

Heerema NA, Byrd JC, Dal Cin PS, Dell' Aquila ML, Koduru PR, Aviram A, Smoley SA, Rassenti LZ, Greaves AW, Brown JR, Rai KR, Kipps TJ, Kay NE, Van Dyke DL; Chronic Lymphocytic Leukemia Research Consortium.

Cancer Genet Cytogenet. 2010 Dec;203(2):134-40. doi: 10.1016/j.cancergencyto.2010.07.128.

15.

Validation of Western common recurrent chromosomal aberrations in Korean chronic lymphocytic leukaemia patients with very low incidence.

Yoon JH, Kim Y, Yahng SA, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Kim HJ, Min CK, Kim DW, Lee JW, Min WS, Park CW, Lim J, Kim Y, Han K, Kim M, Cho SG.

Hematol Oncol. 2014 Dec;32(4):169-77. doi: 10.1002/hon.2103. Epub 2013 Oct 7.

PMID:
24123081
16.

[Detection of Gene Abnormalities in 43 Cases of Chronic Lymphocytic Leukemia by Fluorescence in Situ Hybridization].

Jing Y, Lin S, Wang FT, Yu JW, Jiang F.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Aug;26(4):1038-1043. doi: 10.7534/j.issn.1009-2137.2018.04.016. Chinese.

PMID:
30111404
17.

The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia.

Glassman AB, Hayes KJ.

Cancer Genet Cytogenet. 2005 Apr 1;158(1):88-91.

PMID:
15771912
18.

[Evaluation of fluorescence in situ hybridization value in detection of chronic lymphocytic leukemia].

Wu W, Gu J, Ma L, Wang H, Ni J, Ji W, Shen LJ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Oct;20(5):1095-8. Chinese.

PMID:
23114126
19.

Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.

Aoun P, Blair HE, Smith LM, Dave BJ, Lynch J, Weisenburger DD, Pavletic SZ, Sanger WG.

Leuk Lymphoma. 2004 Aug;45(8):1595-603.

PMID:
15370211
20.

Supplemental Content

Support Center